Sionna Therapeutics, Inc.
NASDAQ: SION0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Michael Cloonan
- Employees
- 41
- Headquarters
- Waltham, United States
- IPO year
- 2025
- Market cap
- $1.9B
- Website
- https://www.sionnatx.com
Loading SION…
Loading profile data…Frequently asked questions about SION
What does Sionna Therapeutics, Inc. (SION) do?
Operating as a biopharmaceutical company, Sionna Therapeutics, Inc. is dedicated to transforming the treatment landscape for individuals with cystic fibrosis. This is achieved by developing innovative medicines designed to restore the normal function of the cystic fibrosis transmembrane conductance regulator.
Where does SION trade?
Sionna Therapeutics, Inc. (SION) trades on the NASDAQ Global Market.
What sector is SION in?
Sionna Therapeutics, Inc. (SION) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Sionna Therapeutics, Inc.?
Michael Cloonan is the chief executive officer of Sionna Therapeutics, Inc. (SION).
Where is Sionna Therapeutics, Inc. headquartered?
Sionna Therapeutics, Inc. is headquartered in United States.
Does SION pay a dividend?
Sionna Therapeutics, Inc. (SION) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SION go public?
Sionna Therapeutics, Inc. (SION) completed its initial public offering in 2025.